Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Nuclear Medicine and Biology
|
October 4, 2016
Copper-64 labeled liposomes for imaging bone marrow
Sang-Gyu Lee, Kishore Gangangari, Teja Muralidhar Kalidindi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 23, 2020
γ-Tocotrienol-Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs
Sang-Gyu Lee, Teja Muralidhar Kalidindi, Hanzhi Lou, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 26, 2021
A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals
Teja Muralidhar Kalidindi, Sang-Gyu Lee, Katerina Jou, et al.
Nature Communications
|
April 26, 2018
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
Michael R McDevitt, Daniel L J Thorek, Takeshi Hashimoto, et al.
Molecular Pharmaceutics
|
May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted Radioimmunodiagnosis
Darren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Cell Reports
|
May 31, 2025
BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways
Rahim Hirani, Subhiksha Nandakumar, Nabila Zaman, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Nuclear Medicine and Biology
|
October 4, 2016
Copper-64 labeled liposomes for imaging bone marrow
Sang-Gyu Lee, Kishore Gangangari, Teja Muralidhar Kalidindi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 23, 2020
γ-Tocotrienol-Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs
Sang-Gyu Lee, Teja Muralidhar Kalidindi, Hanzhi Lou, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 26, 2021
A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals
Teja Muralidhar Kalidindi, Sang-Gyu Lee, Katerina Jou, et al.
Nature Communications
|
April 26, 2018
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
Michael R McDevitt, Daniel L J Thorek, Takeshi Hashimoto, et al.
Molecular Pharmaceutics
|
May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted Radioimmunodiagnosis
Darren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Cell Reports
|
May 31, 2025
BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways
Rahim Hirani, Subhiksha Nandakumar, Nabila Zaman, et al.
Page
of 1